Results 151 to 160 of about 35,871 (258)

Inhibition of PVR with a Tyrosine Kinase Inhibitor, Dasatinib, in the Swine

, 2013
PURPOSE. We tested the efficacy of dasatinib, a Food and Drug Administration (FDA)-approved tyrosine kinase inhibitor, to prevent proliferative vitreoretinopathy (PVR). METHODS.
Kazuhiko Umazume, Lanhsin Liu, Kevin Mcdonald, Henry J Kaplan, Patrick A Scott, Juan P Fernandez De Castro, Shigeo Tamiya   +6 more
core  

SEMA3A in Proliferative Vitreoretinopathy: Exogenous Activity, Endogenous Regulation, and the MicroRNA Hypothesis. [PDF]

Biomedicines
Wang B, Li S, Cao Y, Sun A, Li M, Qu J.
europepmc   +1 more source

Pulmonary vascular reactivity in severe pulmonary hypertension associated with COPD. [PDF]

ERJ Open Res
Jutant EM, Delarche B, Croquette M, Beurnier A, Diaz A, Bironneau V, Caron F, Riou M, Boucly A, Jaïs X, Savale L, Sitbon O, Bertoletti L, Humbert M, Montani D.   +14 more
europepmc   +1 more source

Effective arterial elastance relates more closely to pulsatile than resistive indices during routine haemodynamic assessment of inoperable chronic thromboembolic pulmonary hypertension. [PDF]

ERJ Open Res
Chemla D, Jaïs X, Jevnikar M, Brenot P, Gerges C, Beurnier A, Boucly A, Savale L, Sitbon O, Humbert M, Hervé P, Montani D.   +11 more
europepmc   +1 more source

PVR wt Allele [PDF]

, 2020
openaire   +1 more source

Transcriptomic Association Between Poliovirus Receptor (PVR/CD155) and Claudin Signaling Pathways in Colorectal Cancer. [PDF]

Cancer Diagn Progn
Lehrer S, Rheinstein PH.
europepmc   +1 more source

Bone morphogenetic protein signaling as a key regulator of retinal fibrosis. [PDF]

Proc Natl Acad Sci U S A
Sharma S, Alahdab G, Haque MN, Karkoukli I, Assaf A, Ishida Y, Abu Elasrar A, Moustafa M, Tarek M, Zhang X, Mitton KP, Josifovska N, Petrovski G, Ueharu H, Mishina Y, Al-Shabrawey M.   +15 more
europepmc   +1 more source

Machine Learning to Distinguish Physiologic Causes of Hypoxemia After Bidirectional Glenn Using Bedside Markers. [PDF]

Children (Basel)
Savorgnan F, Pilla P, Visokay S, Ness K, Fiedorek T, Flores S.   +5 more
europepmc   +1 more source

Testing a Prespecified Matrix Transcriptional Programme in Myeloid Cells from Proliferative Vitreoretinopathy Membranes: A Donor-Aware Computational Single-Cell Study. [PDF]

Bioengineering (Basel)
Panos GD.
europepmc   +1 more source

Παράγοντες κινδύνου για την ανάπτυξη Παραγωγικής Υαλοειδοαμφιβληστροειδοπάθειας (PVR). Ανασκόπηση βιβλιογραφίας

Σκοπός: Η παρουσίαση των παραγόντων κινδύνου για την εμφάνιση παραγωγικής υαλοειδοαμφιβληστροειδοπάθειας (ΠΥΑ) (Proliferative Vitreoretinopathy - PVR) κυρίως μετά από χειρουργική επέμβαση αποκατάστασης ρηγματογενούς αποκόλλησης του αμφιβληστροειδούς ...
Gkizis Ilias, Γκίζης Ηλίας
core